All Phenotypes Trp53<tm4Glo> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Trp53^tm4Glo
targeted mutation 4, Guillermina Lozano
MGI:5000493

Summary

8 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Trp53^tm4Glo/Trp53^tm4Glo	involves: 129S7/SvEvBrd * C57BL/6	MGI:5000507
ht2	Trp53^tm1Glo/Trp53^tm4Glo	involves: 129S7/SvEvBrd * C57BL/6	MGI:5000505
ht3	Trp53^tm3.1Glo/Trp53^tm4Glo	involves: 129S7/SvEvBrd * C57BL/6	MGI:5000508
cn4	Trp53^tm1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc/0	involves: 129S7/SvEvBrd * C57BL/6 * CBA	MGI:5000506
cn5	Trp53^tm3.1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc/0	involves: 129S7/SvEvBrd * C57BL/6 * CBA	MGI:5000509
cx6	Mdm4^tm3.1Glo/Mdm4^tm3.1Glo Trp53^tm4Glo/Trp53^tm4Glo	involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N	MGI:5142304
cx7	Mdm2^tm1Glo/Mdm2^tm1Glo Trp53^tm1Glo/Trp53^tm4Glo	involves: 129S7/SvEvBrd * C57BL/6	MGI:5000502
cx8	Mdm2^tm1Glo/Mdm2^tm1Glo Trp53^tm3.1Glo/Trp53^tm4Glo	involves: 129S7/SvEvBrd * C57BL/6	MGI:5000504

Allelic Composition	Trp53^tm4Glo/Trp53^tm4Glo
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased tumor-free survival time ( J:171821 )

• medial survival is 395 days due to tumor development

neoplasm

increased lymphoma incidence ( J:171821 )

• in 32% of mice (including T cell and diffuse)

increased T cell derived lymphoma incidence ( J:171821 )

increased adenocarcinoma incidence ( J:171821 )

• in 7% of mice

increased spindle cell carcinoma incidence ( J:171821 )

increased sarcoma incidence ( J:171821 )

• in 61% of mice (including angiosarcoma and spindle-cell)

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:171821 )

immune system

increased T cell derived lymphoma incidence ( J:171821 )

hematopoietic system

increased T cell derived lymphoma incidence ( J:171821 )

Allelic Composition	Trp53^tm1Glo/Trp53^tm4Glo
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53^tm1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased tumor-free survival time ( J:171821 )

• medial survival is 251 days due to tumor development

neoplasm

abnormal tumor morphology ( J:171821 )

• tumors exhibit interstitial inflammatory cells unlike in tumors from Trp53^tm1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

increased lipoma incidence ( J:171821 )

• in 2% of mice

increased lymphoma incidence ( J:171821 )

• in 34% of mice (including T cell, diffuse, anaplastic, and lymph node)

increased T cell derived lymphoma incidence ( J:171821 )

increased adenocarcinoma incidence ( J:171821 )

• in 2% of mice

increased spindle cell carcinoma incidence ( J:171821 )

increased sarcoma incidence ( J:171821 )

• in 61% of mice (including angiosarcoma, spindle-cell, giant-cell, and anaplastic)

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:171821 )

hematopoietic system

increased T cell derived lymphoma incidence ( J:171821 )

immune system

increased T cell derived lymphoma incidence ( J:171821 )

Allelic Composition	Trp53^tm3.1Glo/Trp53^tm4Glo
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53^tm3.1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased tumor-free survival time ( J:171821 )

• median survival is 160 days due to tumor development

neoplasm

abnormal tumor morphology ( J:171821 )

• tumors exhibit interstitial inflammatory cells unlike in tumors from Trp53^tm3.1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

increased lymphoma incidence ( J:171821 )

• in 60% of mice (including T cell, diffuse, and large cell)

increased adenocarcinoma incidence ( J:171821 )

• in 4% of mice

increased spindle cell carcinoma incidence ( J:171821 )

increased sarcoma incidence ( J:171821 )

• in 37% of mice (including angiosarcoma, spindle-cell, and giant-cell)

Allelic Composition	Trp53^tm1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc/0
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
Trp53^tm1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

extended life span ( J:171821 )

• tamoxifen-treated mice survive longer than Trp53^tm1Glo/Trp53^tm4Glo mice

neoplasm

abnormal tumor pathology ( J:171821 )

• tamoxifen-treated lymphomas exhibit decreased apoptosis response compared with tumors from Trp53^tm3.1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

• tamoxifen-treated tumors exhibit decreased cell proliferation compared with control samples

• angiosarcomas treated with tamoxifen exhibit increased senescence compared with tamoxifen-treated angiosarcomas from Trp53^tm3.1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

• tamoxifen-treatment induces apoptosis and senescence in giant-cell sarcoma

tumor regression ( J:171821 )

• in tamoxifen-treated mice

Allelic Composition	Trp53^tm3.1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc/0
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6 * CBA

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
Trp53^tm3.1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

extended life span ( J:171821 )

• tamoxifen-treated mice survive longer than Trp53^tm3.1Glo/Trp53^tm4Glo mice

neoplasm

abnormal tumor pathology ( J:171821 )

• tamoxifen-treated lymphomas exhibit increased apoptosis response compared with tumors from Trp53^tm1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

• 3 of 5 tamoxifen-treated lymphomas exhibit senescence unlike in tumors from Trp53^tm1Glo/Trp53^tm4Glo Tg(CAG-cre/Esr1*)5Amc mice

• tamoxifen-treated angiosarcomas and lymphomas exhibit senescence

decreased tumor growth/size ( J:171821 )

• tamoxifen-treated mice exhibit little to no tumor growth unlike in control mice

Allelic Composition	Mdm4^tm3.1Glo/Mdm4^tm3.1Glo Trp53^tm4Glo/Trp53^tm4Glo
Genetic Background	involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mdm4^tm3.1Glo mutation (0 available); any Mdm4 mutation (193 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:174368 )

N	• unlike mice homozygous the Mdm4 allele alone, double mutant mice are viable

Allelic Composition	Mdm2^tm1Glo/Mdm2^tm1Glo Trp53^tm1Glo/Trp53^tm4Glo
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mdm2^tm1Glo mutation (0 available); any Mdm2 mutation (54 available)
Trp53^tm1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

postnatal lethality, complete penetrance ( J:171821 )

growth/size/body

decreased body size ( J:171821 )

behavior/neurological

decreased locomotor activity ( J:171821 )

• less mobile

Allelic Composition	Mdm2^tm1Glo/Mdm2^tm1Glo Trp53^tm3.1Glo/Trp53^tm4Glo
Genetic Background	involves: 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mdm2^tm1Glo mutation (0 available); any Mdm2 mutation (54 available)
Trp53^tm3.1Glo mutation (0 available); any Trp53 mutation (240 available)
Trp53^tm4Glo mutation (0 available); any Trp53 mutation (240 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:171821 )

N	• lethality observed in Mdm2^tm1Glo homozygotes is completely rescued with mice surviving beyond 5 weeks

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24